Search
Close this search box.

Buy-Side Due Diligence & Transaction Support

RNA Advisors supports investors and acquirers that are exploring investment opportunities in the life sciences and healthcare industries. We have supported buy-side clients involved in M&A ranging in size from pension plans to Venture Capital and Private Equity funds, to family offices and investors with an industry sub-sector focus (biotechnology, diagnostics, medical devices, digital health, etc.). Our team’s deep experience and our extensive research and financial analysis capabilities give us unique and relevant insights which we leverage for better client investment decisionmaking and transaction support.

Highlighted Case Study

Due Diligence Support (Buy-Side): Fund Manager

Highlighted Case Study

Supporting the Entire Life Cycle: Biotech Company

Highlighted Case Study

Commercial Assessment (Buy-Side): Therapeutic

Highlighted Case Study

Buy-Side Due Diligence: Organ on a Chip

Highlighted Case Study

Fairness Opinion: SPAC Target Company Valuation in Biotech

What Our Clients Say

Sign Up for Periodic Updates

Enter your email address below to receive updates from RNA Advisors.